NCT00014950View on ClinicalTrials.gov

Benefits and Risks of Newborn Screening for Cystic Fibrosis

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Cystic FibrosisLung DiseasePseudomonas Infections
Interventions
PROCEDURE

CF newborn screening

Trial Locations (2)

53201

Children's Hospital of Wisconsin, Milwaukee

53706

University of Wisconsin, Madison

All Listed Sponsors
collaborator

National Center for Research Resources (NCRR)

NIH

lead

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

NCT00014950 - Benefits and Risks of Newborn Screening for Cystic Fibrosis | Biotech Hunter | Biotech Hunter